- Home
- MRK
as 07-04-2025 12:34pm EST
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | RAHWAY |
| Market Cap: | 198.5B | IPO Year: | N/A |
| Target Price: | $113.71 | AVG Volume (30 days): | 18.0M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 6.88 | EPS Growth: | 667.14 |
| 52 Week Low/High: | $73.31 - $129.93 | Next Earning Date: | 07-29-2025 |
| Revenue: | $63,922,000,000 | Revenue Growth: | 4.10% |
| Revenue Growth (this year): | 2.42% | Revenue Growth (next year): | 5.77% |
Latest Merck & Company Inc. (new) News
MRK Breaking Stock News: Dive into MRK Ticker-Specific Updates for Smart Investing
Insider Monkey
18 hours ago
FDA Grants Priority Review for Merck & Co’s (MRK) WINREVAIR
Insider Monkey
18 hours ago
Merck & Co (MRK) Announces the Approval of ENFLONSIA
Simply Wall St.
2 days ago
Top Dividend Stocks To Consider In July 2025
Zacks
2 days ago
Will Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?
GlobeNewswire
3 days ago
Sodium Perborate Market worth $184.0 million in 2030, at 3.7%, says MarketsandMarkets™
Insider Monkey
3 days ago
TD Cowen Maintains Hold Rating on Merck After Enflonsia Vaccine Update
Zacks
3 days ago
Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade
Zacks
4 days ago
Will The Decline in Legacy Drugs Pull Down BMY's Top Line?
Compare MRK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MRK Merck & Company Inc. (new) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.